These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1459529

  • 1. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
    Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, Pisi E.
    Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
    [Abstract] [Full Text] [Related]

  • 2. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L.
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [Abstract] [Full Text] [Related]

  • 3. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
    Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J.
    Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
    Caballería Rovira E, Arago López JV, Masso Ubeda RM, Vidal Clemente JL, Sanchís Closa A.
    Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
    [No Abstract] [Full Text] [Related]

  • 5. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K.
    Dig Dis; 2011 Sep; 29(3):326-32. PubMed ID: 21829025
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.
    Togo S, Tanaka K, Morioka D, Sugita M, Ueda M, Miura Y, Kubota T, Nagano Y, Matsuo K, Endo I, Sekido H, Shimada H.
    Nutrition; 2005 Apr; 21(4):480-6. PubMed ID: 15811769
    [Abstract] [Full Text] [Related]

  • 7. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
    Holecek M.
    Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
    [Abstract] [Full Text] [Related]

  • 8. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
    Bauer AG, Wilson JH, Lamberts SW, Blom W.
    Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 10. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K, Winther MB, Ukida M, Leweling H, Reiter HJ, Bode JC.
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [Abstract] [Full Text] [Related]

  • 11. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
    Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Martines D, Abbiati R.
    J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
    [Abstract] [Full Text] [Related]

  • 12. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
    Sieg A, Walker S, Czygan P, Gärtner U, Lanzinger-Rossnagel G, Stiehl A, Kommerell B.
    Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic oral branched-chain amino acid supplementation in a subpopulation of cirrhotics.
    Dioguardi FS, Brigatti M, Dell'Oca M, Ferrario E, Abbiati R.
    Clin Physiol Biochem; 1990 Nov; 8(2):101-7. PubMed ID: 2361352
    [Abstract] [Full Text] [Related]

  • 14. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
    Kawamura E, Habu D, Morikawa H, Enomoto M, Kawabe J, Tamori A, Sakaguchi H, Saeki S, Kawada N, Shiomi S.
    Liver Transpl; 2009 Jul; 15(7):790-7. PubMed ID: 19562716
    [Abstract] [Full Text] [Related]

  • 15. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K.
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [Abstract] [Full Text] [Related]

  • 16. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients.
    Tangkijvanich P, Mahachai V, Wittayalertpanya S, Ariyawongsopon V, Isarasena S.
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):152-7. PubMed ID: 11023085
    [Abstract] [Full Text] [Related]

  • 17. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.
    Nakaya Y, Harada N, Kakui S, Okada K, Takahashi A, Inoi J, Ito S.
    J Gastroenterol; 2002 Mar; 37(7):531-6. PubMed ID: 12162411
    [Abstract] [Full Text] [Related]

  • 18. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease.
    Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Kobayashi Y, Kido Y.
    Nutr Res; 2012 Jul; 32(7):522-9. PubMed ID: 22901560
    [Abstract] [Full Text] [Related]

  • 19. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G, Parisi G, Banti S.
    Eur J Med; 1993 Jul; 2(7):414-6. PubMed ID: 8258031
    [Abstract] [Full Text] [Related]

  • 20. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K.
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.